Recent advances in point-of-care testing (POCT) system based on upconversion luminescent materials
Source abstract
Abstract
Point-of-care testing (POCT) technology has drawn significant attention due to its simplicity, rapidity, and low cost, without the need for expensive large-scale equipment and complex laboratory specimen processing and analysis. Upconversion nanoparticles (UCNPs) exhibit unique advantages including low background interference, excellent detection stability, and relatively low potential toxicity. As a result, POCT based on up-converting luminescent materials has gradually emerged as a hot research topic in recent years. This paper offers a comprehensive review of the current progress and applications of upconversion luminescent materials within the field of POCT. It places particular emphasis on exploring ways to design and enhance the structure of upconversion luminescent materials, aiming to further optimize POCT detection methodologies. A concise introduction to the current application status of upconversion luminescence-based POCT technology is provided, along with key points and solution ideas for the design and application of UCNPs nanocomposites in POCT.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Biosensors and Analytical Detection · Innovative Microfluidic and Catalytic Techniques Innovation · Luminescence Properties of Advanced Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Point-of-care testing: an overview and a look to the future (Circa 2009, United States)10.1016/j.cll.2009.06.015 ↗
2. Emerging technologies for next-generation point-of-care testing10.1016/j.tibtech.2015.09.001 ↗
3. Analytical quality and effectiveness of point-of-care testing in community pharmacies: A systematic literature review10.1016/j.sapharm.2018.07.013 ↗
4. Emerging challenges in point-of-care testing10.1016/j.cmrp.2019.11.006 ↗
5. Point-of-care periodontitis testing: biomarkers, current technologies, and perspectives10.1016/j.tibtech.2018.05.013 ↗
6. Nanozyme-based point-of-care testing: Revolutionizing environmental pollutant detection with high efficiency and low cost10.1016/j.nantod.2023.102145 ↗
7. The effect of perceived risk of false diagnosis on preferences for COVID-19 testing: Evidence from the United States10.1016/j.jocm.2023.100455 ↗
8. The impact of a positive COVID-19 test on timeliness of radiation in patients receiving brachytherapy10.1016/j.brachy.2024.01.006 ↗
9. Microfluidic-assisted integrated nucleic acid test strips for POCT10.1016/j.talanta.2023.125150 ↗
10. SARS-CoV-2 detection using quantum dot fluorescence immunochromatography combined with isothermal amplification and CRISPR/Cas13a10.1016/j.bios.2022.113978 ↗
11. Recent advances of upconversion nanoparticles-based lateral flow assays for point-of-care testing10.1016/j.trac.2024.117641 ↗
12. Ultrasensitive detection and removal of carbamazepine in wastewater using UCNPs functionalized with thin-shell MIPs10.1016/j.microc.2021.106674 ↗
13. Upconverting nanophosphors for various sensing applications10.1016/j.talo.2024.100302 ↗
14. A ratiometric upconversion nanosensor for visualized point-of-care assay of organophosphonate nerve agent[J]10.1016/j.snb.2016.10.015 ↗
15. Inflammation markers in point-of-care testing (POCT)[J]10.1007/s00216-008-2561-3 ↗
16. A versatile upconversion-based multimode lateral flow platform for rapid and ultrasensitive detection of microRNA towards health monitoring10.1016/j.bios.2024.116135 ↗
17. Point-of-care testing (POCT): Current techniques and future perspectives10.1016/j.trac.2011.01.019 ↗
18. Practical Challenges of Point-of-Care Testing10.1016/j.cll.2023.02.002 ↗
19. Cardiac markers and their point-of-care testing for diagnosis of acute myocardial infarction10.1016/j.clinbiochem.2006.05.011 ↗
20. AIEgens enabled ultrasensitive point-of-care test for multiple targets of food safety: Aflatoxin B1 and cyclopiazonic acid as an example10.1016/j.bios.2021.113188 ↗
21. AIEgens-enhanced rapid sensitive immunofluorescent assay for SARS-CoV-2 with digital microfluidics10.1016/j.aca.2024.342398 ↗
22. Enzymeless electrochemical biosensor platform utilizing Cu2O-Au nanohybrids for point-of-care creatinine testing in complex biological fluids
23. Swellable polymer films containing Au nanoparticles for point-of-care therapeutic drug monitoring using surface-enhanced Raman spectroscopy10.1016/j.aca.2016.01.023 ↗
24. Upconversion nanoparticles: synthesis, surface modification and biological applications10.1016/j.nano.2011.02.013 ↗
25. Upconversion nanoparticles (UCNPs): Synthesis methods, imaging and cancer therapy
26. One-step synthesis of hollow PEI-NaBiF4:Yb3+/Er3+ upconversion nanoparticles for water-responsive luminescent probe10.1016/j.jre.2019.04.022 ↗
27. Tuning specific loss power of CoFe2O4 nanoparticles by changing surfactant concentration in a combined co-precipitation and thermal decomposition method10.1016/j.ceramint.2022.02.251 ↗
28. In-situ confinement of ultra-small NaYF4:Yb3+/Er3+ UCNPs as multifunctional ratiometric thermometer and optical heater10.1016/j.optmat.2023.114069 ↗
29. Transparent sol-gel glass ceramics containing β-NaYF4:Yb3+/Er3+ nanocrystals: Structure, upconversion luminescent properties and optical thermometry behavior10.1016/j.ceramint.2018.06.047 ↗
30. Highly efficient upconversion luminescence in hexagonal NaYF4:Yb3+, Er3+ nanocrystals synthesized by a novel reverse microemulsion method10.1016/j.optmat.2017.10.012 ↗
31. Photon upconversion characteristics of intense green emitting BaYF5:Yb3+,Er3+ nanoclusters prepared by reverse microemulsion10.1016/j.materresbull.2018.08.010 ↗
32. A fluorescent sensor based on single band bright red luminescent core-shell UCNPs for the high-sensitivity detection of glucose and glutathione10.1016/j.aca.2024.342323 ↗
33. Dual-mode luminescent multilayer core-shell UCNPs@SiO2@TEuTbB nanospheres for high-level anti-counterfeiting and recognition of latent fingerprints10.1016/j.apsusc.2021.152395 ↗
34. Enhancing red upconversion emission in NaErF4@NaYF4 core-shell nanoparticles by introducing Yb3+ ions as energy trapping centers10.1016/j.jallcom.2022.168371 ↗
35. Multiple doping effect of LiYF4:Yb3+/Er3+/Ho3+/Tm3+@LiYF4:Yb3+ core/shell nanoparticles and its application in Hg2+ sensing detection10.1016/j.jallcom.2019.07.258 ↗
36. Fluorescence sensor based on molecularly imprinted polymers and core–shell upconversion nanoparticles@metal–organic frameworks for detection of bovine serum albumin10.1016/j.saa.2022.121460 ↗
37. Multi-shell structured nanocarriers with enhanced multiphoton upconversion luminescence efficiency for NIR-mediated targeted photodynamic therapy
38. Immunochromatographic assay integrated smartphone-based device for simultaneous detection of multiple mycotoxins using core-shell up-conversion nanoparticles10.1016/j.snb.2023.134783 ↗
39. Tm3+-doped upconversion nanoparticles water probing10.1016/j.snb.2023.134424 ↗
40. Improving dispersibility of lanthanide-doped upconversion nanoparticles for luminescence applications in medium polarity solvents10.1016/j.jlumin.2023.120192 ↗
41. Excitation pulse width-dependent luminescence decay of lanthanide-doped upconversion nanoparticles10.1016/j.jlumin.2023.120325 ↗
42. Enhanced upconversion luminescence in LaVO4:Yb3+/Er3+ nanorods through Ba2+ ions doping10.1016/j.ceramint.2023.07.165 ↗
43. Rapid detection of zearalenone in cereals using La3+-doped upconversion nanoparticles-based immunochromatographic assay10.1016/j.foodcont.2023.109904 ↗
44. Upconversion nanoparticle-based fluorescence resonance energy transfer sensing of programmed death ligand 1 using sandwich epitope-imprinted polymers10.1016/j.bios.2023.115889 ↗
45. Ligand-sharing growth of upconversion UCNP(NaYbF4:Tm3+)/NMIL(Ti) nanohybrids with extended light absorbance for acetaldehyde photodegradation under high humidity10.1016/j.apcatb.2022.121555 ↗
46. A highly sensitive fluorometric biosensor for Fumonisin B1 detection based on upconversion nanoparticles-graphene oxide and catalytic hairpin assembly10.1016/j.aca.2022.339811 ↗
47. Ultra-rapid transfer of oleic acid-coated hydroxyapatite nanocrystals into water via a sodium citrate-assisted ligand exchange strategy10.1016/j.colsurfa.2023.132464 ↗
48. Solvent-mediated surface ligand exchange to enhance the performance of quantum-dot light-emitting diodes10.1016/j.orgel.2022.106561 ↗
49. The luminescence mechanism of ligand-induced interface states in silicon quantum dots10.1039/D3NA00251A ↗
50. Massive sensitisation of Eu3+ photoluminescence in NaMgF3:Eu nanoparticles by 2-thenoyltrifluoroacetone ligand exchange10.1016/j.jlumin.2023.120251 ↗
51. SPR studies in PVA composite films of SiO2@NaYF4:Er3+/Yb3+ UCNPs via AuNPs concentration variation and their temperature sensing applications10.1016/j.jallcom.2023.171704 ↗
52. The emission quenching of upconversion nanoparticles coated with amorphous silica by fluorescence resonance energy transfer: A mercury-sensing nanosensor excited by near-infrared radiation10.1016/j.saa.2021.119608 ↗
53. Plasmon modulated luminescent modes of upconversion nanoparticle by coupling with AuNR@SiO2 nanostructure10.1016/j.matlet.2023.135121 ↗
54. Amine-functionalized, porous silica-coated NaYF4:Yb/Er upconversion nanophosphors for efficient delivery of doxorubicin and curcumin10.1016/j.msec.2018.11.007 ↗
55. Metallo-graphene enhanced upconversion luminescence for broadband photodetection under polychromatic illumination
56. Improving the performance of upconversion nanoprobe-based lateral flow immunoassays by supramolecular self-assembly core/shell strategies10.1016/j.snb.2020.128233 ↗
57. Recent advances in immuno-based methods for the detection of Ralstonia solanacearum
58. Lateral flow assays: Principles, designs and labels10.1016/j.trac.2016.06.006 ↗
59. Impact of nanotechnology on progress of flow methods in chemical analysis: A review10.1016/j.aca.2023.341643 ↗
60. A sensitive and quantitative prognosis of C-reactive protein at picogram level using mesoporous silica encapsulated core-shell up-conversion nanoparticle based lateral flow strip assay10.1016/j.talanta.2021.122335 ↗
61. Performance enhancement of the lateral flow immunoassay by use of composite nanoparticles as signal labels10.1016/j.trac.2023.117441 ↗
62. Microparticle−based platform for point-of-care immunoassays10.1016/j.ab.2018.02.021 ↗
63. NIR-II emitting rare-earth nanoparticles for a lateral flow immunoassay in hemolysis10.1016/j.snb.2021.130380 ↗
64. Ferroptosis-apoptosis combined anti-melanoma immunotherapy with a NIR-responsive upconverting mSiO2 photodynamic platform10.1016/j.cej.2021.129557 ↗
65. Lateral flow assays (LFA) for detection of pathogenic bacteria: A small point-of-care platform for diagnosis of human infectious diseases10.1016/j.talanta.2022.123330 ↗
66. A rapid and user-friendly assay to detect the Neutrophil gelatinase-associated lipocalin (NGAL) using up-converting nanoparticles10.1016/j.talanta.2016.10.009 ↗
67. Paper-based optical nanosensors – A review10.1016/j.aca.2022.340640 ↗
68. A simple synthesis method of microsphere immunochromatographic test strip for time-resolved luminescence detection of folic acid10.1016/j.foodchem.2023.135599 ↗
69. Recent research trends in fluorescent reporters-based lateral flow immunoassay for protein biomarkers specific to acute myocardial infarction
70. Development of a low-cost portable POCT device based on ARM10.1016/j.procir.2018.01.040 ↗
71. 394 Pre- and post-implementation comparison of the impact of emergency department-based COVID-19 point-of-care testing on emergency department patient metrics10.1016/j.annemergmed.2023.08.422 ↗
72. 403 Comparison of point-of-care testing versus hospital lab testing in the emergency department: a time to results evaluation of the iSTAT Device10.1016/j.annemergmed.2023.08.433 ↗
73. Dual-targets binding protection mediated rolling circle transcription with tandem fluorescent RNA aptamers for label-free detection of liver cancer biomarkers10.1016/j.snb.2024.135521 ↗
74. Application of microfluidic technology based on surface-enhanced Raman scattering in cancer biomarker detection: A review10.1016/j.jpha.2023.08.009 ↗
75. A point-of-care solid-phase colorimetric sensor based on the enzyme-induced metallization for ALP detection
76. Carbon nanomaterials-based electrochemical aptasensor for point-of-care diagnostics of cancer biomarkers
77. A paper-supported aptasensor based on upconversion luminescence resonance energy transfer for the accessible determination of exosomes10.1016/j.bios.2017.12.012 ↗
78. A novel carboxyl polymer-modified upconversion luminescent nanoprobe for detection of prostate-specific antigen in the clinical gray zonebase by flow immunoassay strip10.1016/j.ymeth.2023.05.001 ↗
79. Upconversion nanoparticles-based lateral flow immunoassay for point-of-care diagnosis of periodontitis10.1016/j.snb.2021.129673 ↗
80. An ultrasensitive smartphone-assisted bicolor-ratiometric fluorescence sensing platform based on a “noise purifier” for point-of-care testing of pathogenic bacteria in food10.1016/j.foodchem.2024.138805 ↗
81. Point-of-care detection of pathogenic bacteria based on pregnancy test strips and metal–organic frameworks10.1016/j.microc.2021.107142 ↗
82. Nanomaterials-based fluorescent assays for pathogenic bacteria in food-related matrices10.1016/j.tifs.2023.104214 ↗
83. A smartphone-based fluorescent sensor for rapid detection of multiple pathogenic bacteria10.1016/j.bios.2023.115744 ↗
84. Recent advances in nanotechnology for simultaneous detection of multiple pathogenic bacteria10.1016/j.nantod.2021.101121 ↗
85. Research progress on portable electrochemical sensors for detection of mycotoxins in food and environmental samples10.1016/j.cej.2024.149860 ↗
86. Mycotoxins detection in food using advanced, sensitive and robust electrochemical platform of sensors: A review10.1016/j.sna.2024.115045 ↗
87. The evolution of multiplex detection of mycotoxins using immunoassay platform technologies10.1016/j.jhazmat.2022.128706 ↗
88. Fe-N-C single-atom nanozyme for ultrasensitive, on-site and multiplex detection of mycotoxins using lateral flow immunoassay10.1016/j.jhazmat.2022.129853 ↗
89. An improved up-conversion nanoparticles-based immunochromatographic assay for rapid detection of zearalenone in cereals10.1016/j.foodchem.2023.135555 ↗
90. A portable and universal upconversion nanoparticle-based lateral flow assay platform for point-of-care testing10.1016/j.talanta.2019.03.105 ↗
91. Trends of respiratory virus detection in point-of-care testing: A review10.1016/j.aca.2023.341283 ↗
92. Second near-infrared fluorescent dye for lateral flow immunoassays rapid detection of influenza A/B virus10.1016/j.ab.2022.114847 ↗
93. 3D printed hydrophobic barriers in a paper-based biosensor for point-of-care detection of dengue virus serotypes10.1016/j.talanta.2021.122962 ↗
94. Smartphone-assisted point-of-care testing of nucleic acids based on hybridization chain reaction, magnetic beads, and gold nanorods etching10.1016/j.snb.2023.134111 ↗
95. A smartphone-based quantitative point-of-care testing (POCT) system for simultaneous detection of multiple heavy metal ions10.1016/j.cej.2020.124966 ↗
96. The use of point-of-care testing to establish cause of death in the autopsy setting10.1016/j.jflm.2020.101933 ↗
97. Point-of-care measured serum cholinesterase activity predicts patient outcome following severe burns10.1016/j.burns.2020.10.027 ↗
98. A novel electro-driven immunochromatography assay based on upconversion nanoparticles for rapid pathogen detection10.1016/j.bios.2020.112037 ↗
99. Upconversion luminescence-enhanced full spectral response 1D/2D LaOCl:Yb3+,Er3+/BiOBr nanofiber S-scheme heterojunction photocatalysts for efficient degradation of organic pollutants
100. Defect engineering in heterogeneous catalytic oxidation catalysts for air pollution elimination: A review of recent progress and strategies10.1016/j.jece.2022.108734 ↗